Titelia

Funds holding Can-Fite BioPharma Ltd

ISIN US13471N4097 · Israel · LEI 549300ZLRH6GSBOHFZ59

Fund holders
1
Of which ETFs
0 1 other fund
Value held
155 $

A single tracked fund declares this company. So these figures do not say who owns it.

FundSharesValueWeight in fund
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds 50155 $as of Mar 31, 2026

Download this table: CSV, JSON

Report an error

Institutional managers

13 managers declare this company to the SEC (Form 13F).

ManagerSharesValue
SABBY MANAGEMENT, LLC42,559131.9K $as of Mar 31, 2026
CITADEL ADVISORS LLC34,150105.9K $as of Mar 31, 2026
RHUMBLINE ADVISERS20,90864.8K $as of Mar 31, 2026
HRT FINANCIAL LP19,38360 $as of Mar 31, 2026
Virtu Financial LLC12,90840 $as of Mar 31, 2026
CITIGROUP INC5,48217K $as of Mar 31, 2026
UBS Group AG2,1526.7K $as of Mar 31, 2026
OSAIC HOLDINGS, INC.4501.4K $as of Mar 31, 2026
FIFTH THIRD BANCORP150465 $as of Mar 31, 2026
WELLS FARGO & COMPANY/MN125388 $as of Mar 31, 2026
Activest Wealth Management1031 $as of Mar 31, 2026
MORGAN STANLEY13 $as of Mar 31, 2026
TD Waterhouse Canada Inc.13 $as of Mar 31, 2026
Cite this page

Titelia. "Funds holding Can-Fite BioPharma Ltd". https://titelia.com/en/stocks/can-fite-biopharma-ltd-US13471N4097